Grape King Bio Ltd.(TW:1707)
NT$78.70-0.60 (-0.76%)
TW:1707
Grape King Bio Ltd. financials statements
NT$78.70
At close:-0.60 (-0.76%)
Grape King Bio Ltd. (1707) Ratios
Grape King Bio Ltd. Ratios
TW:1707's free cash flow for Q2 2026 was NT$242.17M. For the 2026 fiscal year, TW:1707's free cash flow was decreased by NT$-36.58M and operating cash flow was NT$278.74M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.65 | 1.68 | 1.66 | 1.56 | 1.51 |
| Quick Ratio | 1.37 | 1.44 | 1.45 | 1.38 | 1.29 |
| Cash Ratio | 1.22 | 1.31 | 1.32 | 1.26 | 1.10 |
| Solvency Ratio | 0.48 | 0.56 | 0.49 | 0.67 | 0.65 |
| Operating Cash Flow Ratio | 0.64 | 0.56 | 0.69 | 0.81 | 0.77 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 363.69 |
| Net Current Asset Value | NT$ 1.99B | NT$ 2.06B | NT$ 2.16B | NT$ 1.89B | NT$ 1.35B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 |
| Debt-to-Equity Ratio | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 |
| Debt-to-Capital Ratio | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Financial Leverage Ratio | 1.52 | 1.52 | 1.55 | 1.57 | 1.56 |
| Debt Service Coverage Ratio | 481.21 | 877.91 | 1025.93 | 1103.00 | 215.08 |
| Interest Coverage Ratio | 457.49 | 823.40 | 983.71 | 1137.03 | 603.21 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.97 | 1.11 | 1.32 | 1.08 | 1.87 |
| Net Debt to EBITDA | -1.47 | -1.32 | -1.48 | -1.44 | -1.19 |
| Profitability Margins | |||||
| Gross Profit Margin | 75.08% | 77.58% | 80.26% | 81.63% | 80.18% |
| EBIT Margin | 20.89% | 23.78% | 25.04% | 25.78% | 24.66% |
| EBITDA Margin | 26.23% | 28.38% | 29.36% | 30.11% | 28.91% |
| Operating Profit Margin | 20.89% | 22.40% | 23.47% | 25.90% | 24.69% |
| Pretax Profit Margin | 22.41% | 23.95% | 25.02% | 25.87% | 24.65% |
| Net Profit Margin | 11.88% | 12.98% | 13.66% | 20.88% | 19.88% |
| Continuous Operations Profit Margin | 18.15% | 19.45% | 20.14% | 20.78% | 19.86% |
| Net Income Per EBT | 53.02% | 54.18% | 54.60% | 80.72% | 80.67% |
| EBT Per EBIT | 107.29% | 106.94% | 106.57% | 99.87% | 99.81% |
| Return on Assets (ROA) | 7.74% | 9.45% | 9.37% | 14.41% | 13.85% |
| Return on Equity (ROE) | 11.78% | 14.40% | 14.56% | 22.67% | 21.67% |
| Return on Capital Employed (ROCE) | 17.39% | 20.83% | 21.04% | 23.73% | 22.47% |
| Return on Invested Capital (ROIC) | 14.00% | 16.84% | 16.86% | 19.08% | 18.03% |
| Return on Tangible Assets | 7.79% | 9.53% | 9.44% | 14.46% | 13.89% |
| Earnings Yield | 4.25% | 6.54% | 6.29% | 8.72% | 8.25% |
| Efficiency Ratios | |||||
| Receivables Turnover | 27.80 | 33.26 | 33.72 | 36.59 | 31.22 |
| Payables Turnover | 7.02 | 8.09 | 7.24 | 6.50 | 7.22 |
| Inventory Turnover | 2.61 | 3.08 | 2.85 | 2.77 | 2.70 |
| Fixed Asset Turnover | 1.26 | 1.42 | 1.37 | 1.38 | 1.32 |
| Asset Turnover | 0.65 | 0.73 | 0.69 | 0.69 | 0.70 |
| Working Capital Turnover Ratio | 4.54 | 4.79 | 4.75 | 5.50 | 9.06 |
| Cash Conversion Cycle | 101.11 | 84.51 | 88.55 | 85.41 | 96.31 |
| Days of Sales Outstanding | 13.13 | 10.97 | 10.82 | 9.98 | 11.69 |
| Days of Inventory Outstanding | 139.99 | 118.68 | 128.16 | 131.61 | 135.16 |
| Days of Payables Outstanding | 52.00 | 45.13 | 50.44 | 56.18 | 50.54 |
| Operating Cycle | 153.11 | 129.65 | 138.99 | 141.58 | 146.85 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 9.63 | 12.66 | 17.01 | 20.19 | 17.23 |
| Free Cash Flow Per Share | 7.66 | 8.29 | 12.95 | 16.80 | 15.34 |
| Dividend Paid and CapEx Coverage Ratio | 1.49 | 1.12 | 1.55 | 2.13 | 2.07 |
| Capital Expenditure Coverage Ratio | 4.89 | 2.90 | 4.19 | 5.95 | 9.13 |
| Operating Cash Flow Coverage Ratio | 10.14 | 11.66 | 13.06 | 18.96 | 9.35 |
| Operating Cash Flow to Sales Ratio | 0.21 | 0.17 | 0.24 | 0.29 | 0.26 |
| Free Cash Flow Yield | 6.06% | 5.54% | 8.30% | 10.00% | 9.59% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 15.39 | 15.27 | 15.90 | 11.47 | 12.12 |
| Price-to-Sales (P/S) Ratio | 2.79 | 1.98 | 2.17 | 2.40 | 2.41 |
| Price-to-Book (P/B) Ratio | 2.77 | 2.20 | 2.32 | 2.60 | 2.63 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 16.51 | 18.03 | 12.04 | 10.00 | 10.43 |
| Price-to-Operating Cash Flow Ratio | 13.14 | 11.81 | 9.17 | 8.32 | 9.29 |
| Price-to-Earnings Growth (PEG) Ratio | -0.96 | -74.90 | -0.48 | 1.04 | -2.34 |
| Enterprise Value Multiple | 9.18 | 5.67 | 5.92 | 6.51 | 7.15 |
| Enterprise Value | 24.69B | 17.96B | 18.48B | 20.37B | 20.25B |
| EV to EBITDA | 9.18 | 5.67 | 5.92 | 6.51 | 7.15 |
| EV to Sales | 2.41 | 1.61 | 1.74 | 1.96 | 2.07 |
| EV to Free Cash Flow | 14.24 | 14.63 | 9.63 | 8.19 | 8.94 |
| EV to Operating Cash Flow | 11.33 | 9.58 | 7.33 | 6.81 | 7.96 |
| Tangible Book Value Per Share | 52.82 | 78.79 | 77.69 | 74.91 | 70.46 |
| Shareholders’ Equity Per Share | 45.68 | 67.88 | 67.38 | 64.60 | 60.92 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.19 | 0.19 | 0.20 | 0.19 | 0.19 |
| Revenue Per Share | 45.28 | 75.34 | 71.82 | 70.15 | 66.40 |
| Net Income Per Share | 5.38 | 9.78 | 9.81 | 14.65 | 13.20 |
| Tax Burden | 0.53 | 0.54 | 0.55 | 0.81 | 0.81 |
| Interest Burden | 1.07 | 1.01 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
| SG&A to Revenue | 0.52 | 0.53 | 0.54 | 0.54 | 0.54 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.79 | 0.70 | 1.73 | 1.11 | 1.05 |
Currency in TWD
